ArticleJournal for immunotherapy of cancer2021

Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma.

Mitchell Evers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.